The risk of transfer of vancomycin resistance to staphylococci is a real possibility and has been achieved in the laboratory. Prolonged colonization occurs with vancomycin-resistant Enterococcus (VRE), and many more patients are colonized than infected. The failure to identify, isolate, and adhere to infection control measures when caring for VRE-colonized patients dooms to failure any means to control its spread. Control of vancomycin use alone is unlikely to greatly affect the number of patients at risk for VRE colonization. The global spread of VRE may be impossible to stop, but infection control measures are the most important line of defense inside hospitals. Arch Surg. 1996;131:1061-1068
Davis JM, Huycke MM, Wells CL, et al. Surgical Infection Society Position on Vancomycin-Resistant Enterococcus. Arch Surg. 1996;131(10):1061–1068. doi:10.1001/archsurg.1996.01430220055013
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: